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fusion improvements and granulation tissue formation4. 
We present two kidney transplantation patients that were 
NPWT treated, beacuse of wound infections and dehis-
cence.
Case Report
A 48-year-old woman with ESRD was admitted to our 
hospital for a planned kidney transplantation. The cause 
of her ESRD was chronic glomerulonephritis. There was 
good human leukocyte antigen (HLA) match, with only 
two mis-matches. After transplantation (deceased donor), 
an immunosuppression therapy was started, which in-
cluded tacrolimus, mycophenolate mofetil and high-dose 
corticosteroids. The sixth day after transplantation, the 
patient developed a deep wound infection with dehiscence 
that was associated with a copious discharge. Next, the 
wound was opened, debridement was performed, and the 
wound was prepared for NPWT. A porous sponge was 
Kidney transplantation is the best treatment modality 
for patients with end-stage renal disease (ESRD)1. Com-
pared with patients on haemodialysis, transplanted pa-
tients have a better survival rate and quality of life. Still, 
transplantation is major surgical procedure with possible 
surgical and immunological complications. Delayed wound 
healing is a complication that causes signifi cant morbid-
ity and prolonged hospital stays.
The treatment of wounds with negative pressure was 
fi rst described in 1993 by Fleischmann2. His group applied 
negative pressure on open fractures, which resulted in 
improved granulation tissue formation with no bone infec-
tions. Later, this therapy was used in the treatment of 
traumatic, acute and chronic wounds. Currently, negative 
pressure wound therapy (NPWT) is used in almost all 
fi elds of medicine and can be applied to nearly every body 
region3. The principles of this therapy are based on the 
application of uniform negative pressure, which helps 
draw wounds closed and removes infectious materials and 
interstitial fl uid. This leads to tissue decompression, per-
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A B S T R A C T
Kidney transplantation is the best treatment modality for patients with end-stage renal disease. Wound healing is 
impaired in these patients, and factors such as immunosuppression, older age and comorbidities have a negative impact 
on wound healing. Recently, negative pressure wound therapy has become an important wound management technique. 
We present two patients with wound healing issues in the early posttransplant period. In both patients, an immunosup-
pressive treatment was administered, which included tacrolimus, mycophenolate mophetil and high-dose corticosteroids 
with anti-IL-2 induction therapy. Postoperatively, the wounds became infl amed with dehiscence. Negative pressure wound 
therapy was successfully applied to aid the wound healing. The treatment duration period was two weeks for one patient 
and three weeks for the other. After the treatment period, the wounds were signifi cantly improved and were closed. After 
the secondary wound closures, the posttransplant course was uneventful in both patients. Presently, one and three years 
after the transplantations, both patients have well functioning kidneys. According to our limited experience, negative 
pressure wound therapy is a feasible and effective dehiscence wound treatment following kidney transplantation.
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fashioned to the specifi c size and shape of the wound and 
was situated within the wound. An evacuation tube was 
embedded in the sponge, thus ensuring an equal pressure 
distribution to all spaces within the system. The wound 
site was then covered with an adhesive drape, thereby 
converting the open wound into a controlled closed wound. 
An evacuation tube was connected to a canister where the 
effl uent wound fl uid was collected, and the latter was con-
nected to an adjustable vacuum pump that generated 
negative pressure (usually 125 mmHg). The main unit 
delivered negative (subatmospheric) pressure to the wound 
site, which was applied by tubing that decompressed the 
foam dressing, continuously or intermittently. We started 
with the continuous mode and, after a few changes, 
switched to an intermittent mode (5 minutes on and 2 
minutes off). The sponge was changed at the bedside every 
72 hours, and the wound was reexamined. There was a 
progressive reduction in the wound size, and the develop-
ment of healthy granulation tissue was evident. Addition-
ally, a swab from the wound was taken and appropriate 
antibiotics were administered. Three weeks after the 
NPWT was started, a secondary closure was performed. 
Six weeks after the kidney transplantation, the patient 
developed hydronephrosis, which was caused by stenosis 
of a ureterovesical anastomosis. Antegrade dilatation of 
the stenosis failed; however, the patient was successfully 
treated with a Boari fl ap. Now, three years after the kid-
ney transplantation, the kidney function is normal.
The second patient was a 61-year-old man. The cause 
of his renal insuffi ciency was granulomatous glomerulo-
nephritis, which was caused by Wegener’s granulomatosis. 
There was a good HLA match, with three mis-matches 
and immunosuppression therapy was started with tacro-
limus, mycophenolate mofetil and high-dose corticoste-
roids. Because of a wound infection, we opened the wound 
and NPWT was administered. The procedure was identi-
cal to the fi rst patient’s, and two weeks later, the wound 
was secondarily closed. In the early postoperatively 
course, the patient developed complete urinary retention 
and a transurethral resection of the prostate was success-
fully conducted. The further postoperative clinical course 
was uneventful, and the transplanted kidney function was 
excellent one year after transplantation.
The University Hospital Rijeka ethics committee ap-
proved the patients medical record use, and informed con-
sent was obtained from both patients.
Discussion 
NPWT is a non-invasive, dynamic and unique system 
that helps to promote wound healing5,6. The two basic fac-
tors for wound dressing based wound healing are occlusion 
and absorption. Reepithelisation is faster with occlusive 
dressing compared with exposed wounds that are allowed 
to dry7. Excessive exudate causes skin maceration around 
the wound and allows bacterial growth, all of which im-
pairs wound healing8. NPWT using the occlusion and ab-
sorption principles has benefi cial wound healing effects. 
Moreover, the NPWT effects are a product of tissue strain, 
as well as reduced infl ammation and bacterial load. Sub-
atmospheric pressure induce microdeformations or tissue 
strain. The strain promotes cellular proliferation, growth 
factors elaboration and angiogenesis9. Additionally, 
NPWT reduces the amount of oedema fl uid, proteolytic 
enzymes, acute phase proteins, metaloproteases, proin-
fl ammatory mediators and cytokines, and also increases 
blood fl ow in the tissue10. NPWT also reduces bacterial 
load in the wound, decreases interstitial fl uid and im-
proves the local blood fl ow3.
Local infections, hypoxia, trauma, foreign bodies or 
systemic problems such as diabetes mellitus, malnutrition 
or immunodefi ciency are most frequently responsible for 
delays in wound healing3. Before NPWT use, the wound 
must be cleaned of debris and necrotic tissue, with ade-
quate wound bed preparation and patient comorbidity 
optimisation. NPWT complications include infections 
(which are related to the dressing piece retention in the 
wound), bleeding and even death (caused by bleeding from 
the exposed vessels)3. Careful patient selection and serious 
management with the NPWT materials are the best meth-
ods for complication prevention. The NPWT contraindica-
tions include exposed organs (as well as vessels and 
nerves), exposed anastomotic sites, malignancy (in the 
wound), untreated osteomyelitis, nonenteric and unex-
plored fi stulas, necrotic tissue and active bleeding.
NPWT has become a mainstay treatment of acute and 
chronic wounds, such as chronic venous and diabetic foot 
ulcers, open fractures, pressure ulcers, infected sternal 
and mediastinal wounds, skin grafts and open abdo-
mens3,11,12. After determining the need for NPWT, fi lter 
material type, wound contact layer and pressure levels 
still must be assessed. The fi ltering material that can be 
used (under occlusive dressing) includes black foam, white 
foam and gauze; however, there is no evidence indicating 
which one is best. The wound contact layer allows for 
easier removal of the fi lter material, which leads to less 
damage to the underlying structures (e.g., exposed bowel 
or mediastinal wounds). The accepted pressure for treat-
ing the wounds is 125 mmHg because this pressure best 
promotes granulation formation13. NPWT can be used 
with intermittent or continuous negative pressure.
Kidney transplantation procedured use immunosup-
pression therapies to prevent graft rejection. Some im-
munosuppressive drugs, such as corticosteroids and 
mTOR inhibitors, have a negative impact on wound heal-
ing. This results in prolonged hospitalisation and delayed 
recuperation. Despite improvements in the surgical tech-
niques and antibiotic prophylaxis, improper wound heal-
ing is still a problem in transplanted patients1.
Data regarding NPWT use in kidney transplantation 
patients are limited. Shreshta et al. reported 9 patients 
with wound dehiscence after kidney transplantation and 
treated them with NPWT14. The NPWT system was re-
moved after a median of 9 days (range 3–30 days) and 
complete healing was achieved in all patients. The median 
hospital stay after the NPWT initiation was signifi cantly 
shorter compared with conventional wound treatments. 
There were no noticeable complications related to wound 
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therapy. Heap et al. described two patients where NPWT 
was used to heal complex urinary fi stula wounds following 
renal transplantation into an ileal conduit15. They used a 
negative pressure of 75 mm Hg instead of the standard 
125 mm Hg. The authors fi nally stated that the use of 
NPWT might be very helpful in some selected urinary 
fi stula cases. In contrast, Ortiz et al. reported that the use 
of NPWT slowed neocystoureterostomy healing, which 
perhaps lead to the development of a urine leak16.
According to our limited NPWT assisted wound heal-
ing experience, reduced hospital stays and simplifi ed 
wound management were observed in the transplanted 
patients. The device provided a sterile and closed drainage 
system and, in that way, reduced the possibility of infec-
tions which is a very important issue in immunosup-
pressed patients with immunosupression. A prospective 
study with more patients is needed to examine the useful-
ness of NPWT in this group of patients.
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ULOGA TERAPIJE NEGATlVNIM TLAKOM U LIJEČENJU RANA NAKON TRANSPLANTACIJE 
BUBREGA
S A Ž E T A K
Transplantacija bubrega je najbolja metoda liječenja bolesnika u završnom stadiju bubrežnoga zatajenja. U tih bole-
snika postoji problem zaraštavanja rane, a čimbenici kao što su imunosupresija, starija dob i popratna oboljenja imaju 
negativni učinak na cijeljenje rana. Terapija s negativnim tlakom je novija metoda liječenja koja pomaže cijeljenju rana. 
Prikazujemo dva bolesnika koji su imali problem s cijeljenjem rane u ranom razdoblju nakon transplantacije bubrega. 
Primjenjena imunosupresivna terapija se sastojala od takrolimusa, mikofenolat-mofetila, visokih doza kortikosteroida 
uz anti-IL-2 indukcijsku terapiju. Postoperativno je došlo do upale rane s dehiscijencijom. Kod bolesnika je uspješno 
primjenjena terapija s negativnim tlakom kroz dva odnosno tri tjedna. S obzirom na znatno poboljšanje rane korištenjem 
negativnoga tlaka ista je sekundarno zatvorena. Kasniji posttransplantacijski tijek je bio uredan. Danas, jednu i tri 
godine nakon transplantacije bubrega oba pacijenta imaju dobro funkcionirajući bubreg. Terapija negativnim tlakom je, 
prema našem ograničenom iskustvu, efi kasna metoda u liječenju rana s dehiscijencijom nakon transplantacije bubrega.
